The Swedish HTA agency TLV has announced changes to the timeline and content of its upcoming guidance on reimbursement and pricing of medicines.
Key points from the update:
📍The previously communicated timeline has been postponed. The revised guidance will enter into force […]
Day 2 at SHEA highlighted a broader perspective: health economics extends well beyond traditional pharmacoeconomic frameworks.
Discussions included applications across:
📍social care alongside healthcare
📍the health economic value of green outdoor environments
Closer to our core areas, two themes stood out:
➡️ the continued importance […]
Day 1 in Lund highlighted a clear direction: global policy shifts are increasingly shaping local HTA realities.
External changes, including US MFN policy, are already influencing the pharmaceutical landscape beyond their origin.
Less than a year on, the impact feels well embedded.
At […]
Choosing the right study design for the causal question
We are proud to share that a paper co-authored by Jessica Young is among the Top 10 most-cited papers in Pharmacoepidemiology and Drug Safety for 2024.
The paper, “Core Concepts in Pharmacoepidemiology: New-User Designs,” explores how […]
Expanding our Evidence, Review & Synthesis team
We are pleased to welcome Dr. Gulchehak Kaur to Quantify Research.
Gulchehak joins our Evidence, Review and Synthesis team with a strong foundation across clinical and economic disciplines:
📓Undergraduate degree in Dentistry
📓MSc in Health Economics, Manipal […]
We are pleased to welcome Sami Gabbouj to Quantify Research as Project Leader.
Sami brings more than 10 years of experience across the biomedical field, combining scientific depth with business understanding.
His approach reflects a core challenge in our field:
➡️ translating clinical […]
We are pleased to welcome Emilia Larsson to Quantify Research as Senior HR Business Partner.
Emilia brings ~8 years of HR experience across international organisations in tech, medtech, healthcare, and life sciences.
Her background includes:
• […]
After exploring real-world data sources across the Nordic countries, we now pivot to how this data is used in regulatory evidence generation.
One important example is Post-Authorisation safety Studies (PASS).
The PASS framework is specific to the European Union regulatory system.
Other regulators, […]
Den 5 maj är Anders Gustavsson vid Quantify med och arrangerar ett digitalt seminarium om hur vi i Sverige kan förbereda oss inför kommande sjukdomsmodifierande behandling vid Alzheimers sjukdom. Den primära målgruppen är kliniskt verksamma inom kognitiva sjukdomar men alla […]
We are pleased to welcome Volmar Kaipainen to Quantify Research as a Research Associate, based in our Helsinki office.
Volmar holds a bachelor’s degree in Econometrics and a master’s degree in Statistics from […]